Farther Finance Advisors’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
MAP
CWP
GA
AWM
GI
WWM
Farther Finance Advisors's CAPR Position: Q2 2026 in Review
Farther Finance Advisors held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 36 shares worth $867. The position accounts for ﹤0.01% of the portfolio, ranked #5409.
Farther Finance Advisors first reported a position in CAPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $28K in Q3 2025. 7 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.
- Farther Finance Advisors held 36 shares of Capricor Therapeutics worth $867 as of Q2 2026.
- Farther Finance Advisors left its Capricor Therapeutics share count unchanged in Q2 2026.
- Capricor Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5409 holding.
- Farther Finance Advisors first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 4 quarters since.
- Farther Finance Advisors's Capricor Therapeutics position peaked at $28K in Q3 2025.
- 7 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.